Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0B9LI
|
||||
Former ID |
DNC014463
|
||||
Drug Name |
(+/-)-threo-N-(2-Methylpyridine)methylphenidate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531163] | ||
Structure |
Download2D MOL |
||||
Formula |
C20H24N2O2
|
||||
Canonical SMILES |
COC(=O)C(C1CCCCN1CC2=CC=CC=N2)C3=CC=CC=C3
|
||||
InChI |
1S/C20H24N2O2/c1-24-20(23)19(16-9-3-2-4-10-16)18-12-6-8-14-22(18)15-17-11-5-7-13-21-17/h2-5,7,9-11,13,18-19H,6,8,12,14-15H2,1H3/t18-,19-/m1/s1
|
||||
InChIKey |
AZQUBJDTVAIXBC-RTBURBONSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Sodium-dependent dopamine transporter | Target Info | Inhibitor | [531163] | |
Pathway Interaction Database | Alpha-synuclein signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.